Public stocks have a price. Private stocks have estimates — and the gap between those two ideas is the single most misunderstood thing about pre-IPO investing.
Consider Anthropic in mid-2026. Its last primary funding round (Series H, May 2026) valued the company at $965 billion. Two months later, secondary-market activity implied roughly $1.2 trillion. Same company, same quarter, a difference of over $200 billion depending on which number you looked at. Neither was wrong. They were measuring different things.
This guide explains how pre-IPO shares actually get priced, why the same company can carry several valuations at once, and how to read a private-market price before you commit capital.
Why There's No Single Pre-IPO Share Price
A public stock price exists because thousands of buyers and sellers transact continuously on an exchange, and every trade is reported to a consolidated tape. Private markets have none of that infrastructure. There's no exchange, no continuous trading, and no public reporting requirement.
What exists instead is a set of reference points, each generated by a different mechanism:
Price source | What it reflects | How current is it? |
|---|---|---|
Primary round valuation | What institutional investors paid for newly issued shares, with negotiated terms and protections | Point-in-time; can be months or years stale |
Secondary transaction prices | What buyers and sellers of existing shares actually agreed to | More current, but sporadic and uneven |
Tender offer price | A company-set price in a structured liquidity event | Current at the time of the tender window |
409A valuation | An independent appraisal for employee option-pricing purposes | Usually annual; typically conservative |
Bid/ask indications | What buyers say they'd pay and sellers say they'd accept | Live, but indicative — not executed trades |
Understanding which source a headline number came from is most of the work. A "$1.2 trillion valuation" derived from thin secondary activity is a fundamentally different claim than a $965 billion priced primary round with institutional due diligence behind it.
Why Primary and Secondary Prices Diverge
It's tempting to assume a higher secondary price means the company got more valuable. Often something else is happening.
Scarcity, not fundamentals
In a hot name, far more people want to buy than current holders want to sell. Employees are restricted, early investors are holding for an expected IPO, and the company may limit transfers entirely. That supply-demand imbalance pushes secondary prices up regardless of any change in the business.
Menlo Ventures' Matt Murphy has described secondary valuations as a "noisy signal" driven by scarcity and buyer/seller imbalance — a useful phrase to keep in mind whenever a secondary print makes headlines.
Different securities, different rights
A primary round almost always buys preferred stock, which typically carries liquidation preferences, anti-dilution protection, information rights, and sometimes board representation. Secondary buyers usually get common stock, or an interest in a vehicle holding common stock, with none of those protections.
Comparing a preferred-share price to a common-share price without adjusting for those rights is comparing two different products. Common stock genuinely should trade at a discount to preferred, all else equal.
Information asymmetry
Institutional investors in a primary round get audited financials, management access, and a formal diligence process. Secondary buyers frequently get far less. Some of the price gap is a discount for operating with less information — or a premium paid by buyers operating on sentiment.
Staleness
A primary round is a snapshot. If a company raised twelve months ago and has since tripled revenue, the primary valuation is simply out of date. Secondary prices, imperfect as they are, at least move.
What Actually Drives Pre-IPO Valuations
Underneath the noise, private valuations respond to a recognizable set of inputs:
Revenue and growth rate. The dominant driver for late-stage companies. Anthropic's reported ~$30 billion annualized revenue with roughly 1,400% year-over-year growth is why its valuation moved as fast as it did.
Public-market comparables. Private valuations are anchored to the multiples that similar public companies trade at. When public software or AI multiples compress, private marks follow — usually with a lag.
Path and proximity to liquidity. A company that has confidentially filed for an IPO carries less timing risk than one with no visible exit. Anthropic's June 2026 confidential filing materially changed its risk profile.
Sector sentiment. Roughly 92% of the 2026 IPO pipeline's most-watched names are AI or AI-adjacent. Sector enthusiasm lifts and depresses whole cohorts at once.
Transfer restrictions. The harder a company makes it to sell shares, the thinner and more volatile its secondary pricing.
Indicative vs. Executable: The Distinction That Matters Most
If you take one thing from this article, take this: an indicative price is not a price you can trade at.
Indicative pricing is a reference — derived from past transactions, funding rounds, or non-binding interest. It tells you roughly where a name has been marked.
Executable pricing is what a real, verified counterparty will actually transact at right now, for your size, with your structure.
Most published private-company valuations — including nearly every figure quoted in financial media — are indicative. The spread between an indicative mark and an executable price can be wide, particularly in scarce names, small sizes, or unusual structures.
How to Read a Pre-IPO Price Responsibly
Identify the source. Primary round, secondary trade, tender, or indication? Each means something different.
Check the date. A valuation without a date is not information.
Ask which security. Preferred or common? Direct shares or an interest in a vehicle?
Look for corroboration. A single print in a thin market is weak evidence. Several transactions clustering in a range is stronger.
Account for fees. Platform fees ranging from roughly 2% to nearly 7% per side materially change your effective entry price.
Assume you cannot mark to market. There's no daily quote on a private position, and you may hold it for years.
Reference Pricing on AllocationsX
The practical fix for opaque pricing is context. AllocationsX provides reference pricing data across 300+ pre-IPO companies so neither side of a trade is negotiating blind, inside a regulated execution framework:
Reference pricing data showing where a name has been marked across secondary activity and funding rounds.
Regulated ATS execution — AllocationsX is operated by Allocations Securities, LLC, an SEC-registered broker-dealer and member of FINRA and SIPC, running an Alternative Trading System under Regulation ATS.
Verified counterparties on both sides, so quoted interest comes from accredited participants.
Two-way market — seeing both buy and sell interest is itself a pricing signal.
See current reference pricing across 300+ private companies. Launch the AllocationsX app →
FAQ: Pre-IPO Share Pricing
How are pre-IPO shares priced?
There's no single exchange price. Pre-IPO shares are priced by reference to the last primary funding round, recent secondary transactions, company tender offers, 409A appraisals, and live bid/ask indications — with the final price negotiated between buyer and seller.
Why is a company's secondary valuation different from its funding round?
Because they measure different things. Primary rounds price newly issued preferred stock with negotiated protections; secondaries price existing common stock, often under scarcity conditions. Anthropic's ~$1.2 trillion secondary-implied mark versus its $965 billion May 2026 primary round is a clear example.
What does "indicative, not executable" mean?
An indicative price is a reference point drawn from past activity or non-binding interest. An executable price is what a real counterparty will transact at now, for your size and structure. Most published private valuations are indicative.
Can I trust a pre-IPO valuation I read in the news?
Treat it as a directional signal, not a price. Analysts describe secondary valuations as a "noisy signal" driven by scarcity and buyer/seller imbalance. Always check the source, the date, and which class of security it refers to.
Do fees affect my effective price?
Significantly. Platform fees across the industry range from roughly 2% to nearly 7% per side. A 5% fee on entry means the company's value must rise 5% before you break even, so fee structure is part of the price.
AllocationsX is operated by Allocations Securities, LLC, an SEC-registered broker-dealer and member of FINRA and SIPC, operating an Alternative Trading System under Regulation ATS. Available to accredited and qualified investors only; verification required. Private investments involve significant risk, including illiquidity and possible loss of principal. Valuations referenced are indicative, based on secondary-market activity or last funding rounds, and may not reflect executable prices. Nothing in this article constitutes tax, legal, investment, or accounting advice.
